-

Avoro Ventures Adds Sara Nayeem, MD, as a Partner

NEW YORK--(BUSINESS WIRE)--Avoro Ventures announced today that Sara Nayeem, MD, has joined the firm as a Partner, focused on its venture capital investment efforts.

Dr. Nayeem joins Avoro Ventures after 12 years with New Enterprise Associates, Inc. (NEA), where she was a Partner in the firm’s biopharma investment practice serving on numerous company boards, in addition to providing support to fundraising, recruiting, and diversity and mentoring initiatives. She will source and manage private market investments within the biotechnology sector spanning early stage to late stage and cross-over, joining Behzad Aghazadeh, PhD, Managing Partner of Avoro Ventures and Avoro Capital Advisors, and Dr. Garheng Kong, Avoro Ventures Advisory Partner.

About Avoro Ventures

Avoro Ventures is an affiliated company of Avoro Capital Advisors, an SEC-registered investment manager based in New York City, with over $5.4 billion in capital primarily focused on life sciences and biotechnology.

Contacts

Andy Merrill
Prosek Partners
amerrill@prosek.com
917-622-1252

Industry:

Avoro Ventures

Release Versions
English

Contacts

Andy Merrill
Prosek Partners
amerrill@prosek.com
917-622-1252

More News From Avoro Ventures

Avoro Ventures Adds Mark Chin as a Partner

NEW YORK--(BUSINESS WIRE)--Avoro Ventures, a global venture capital firm investing in life sciences, announced today that Mark Chin has joined the firm as a Partner, focused on its venture capital investment efforts. Mark has 15 years of healthcare experience across venture capital, strategy consulting, business and corporate development. Prior to joining Avoro Ventures, Mark was a Managing Director at Arix Bioscience focused on private and public biotech investments. During his time at Arix, h...

Avoro Ventures Announces Final Close of Inaugural Fund and Adds Uya Chuluunbaatar as a Partner

NEW YORK--(BUSINESS WIRE)--Avoro Ventures, a global venture capital firm investing in life sciences, announced the final close of its inaugural fund, Avoro Ventures Fund L.P. (“The Fund”), with $186 million in total of capital commitments. The launch of Avoro Ventures serves as an extension to the established life sciences business at Avoro Capital, creating a distinct, complimentary portfolio of private market investments. The Fund has completed three investments and will continue to pursue de...
Back to Newsroom